The UAE's health authority has approved a new oral treatment for obesity, set to be available to the public starting May 2024. This initiative is part of the country's efforts to combat obesity and improve the health of its citizens and residents.
The UAE has announced the approval of a new weight loss medication that is taken daily in pill form, eliminating the need for injections. This development marks a significant step in addressing obesity in the region.
Researcher Boris Gladkikh from Volgograd Technical University reveals ongoing efforts to develop new pharmaceutical compounds aimed at inhibiting the defense systems of cancer cells, making them more susceptible to traditional treatments. This innovation comes at a time when cancer cases are on the rise globally.
Lilly has announced the launch of a new obesity treatment, generating significant interest on Wall Street despite strong competition from Novo Nordisk. The drug is expected to achieve sales in the billions.
A research team from Carthage University in Tunisia has identified remarkable healing potentials in four plants from the southern desert, paving the way for new commercial drug developments.
Russian researchers have revealed the role of modified CRYAB protein in breaking down toxic protein aggregates linked to Parkinson's disease, paving the way for new drug development. This discovery is crucial for advancing treatment options for this neurodegenerative disorder affecting millions worldwide.